BBLG
Bone Biologics Corporation
1.37
1 x 0.96
2 x 1.80
bid
ask
-
0.03
2.14%
10:05 AM
timesize
| Ytd | -5.52% | |
| 1y | -62.15% |
1.34
day range
1.37
1.05
52 week range
4.13
| Open | 1.34 | Prev Close | 1.40 | Low | 1.34 | High | 1.37 | Mkt Cap | 2.46M |
| Vol | 7.27K | Avg Vol | 49.15K | EPS | -1.16 | P/E | N/A | Forward P/E | -0.41 |
| Beta | 0.74 | Short Ratio | 0.18 | Inst. Own | 4.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 1.31 | 200-d Avg | 1.60 | 1yr Est | 16.75 |
| Income Statement | |||
| Operating Expenses | 805.05K | ||
| Research and Development Expense | 141.60K | ||
| Selling, General and Administrative Expense | 663.46K | ||
| Operating Income | -805.05K | ||
| Net Income | -765.99K | ||
| Net Income Common Stock | -765.99K | ||
| Net Income Common Stock (USD) | -765.99K | ||
| Consolidated Income | -765.99K | ||
| Earnings per Basic Share | -0.43 | ||
| Earnings per Basic Share (USD) | -0.43 | ||
| Earnings per Diluted Share | -0.43 | ||
| Earning Before Interest & Taxes (EBIT) | -765.99K | ||
| Earning Before Interest & Taxes (USD) | -765.99K | ||
| Weighted Average Shares | 1.80M | ||
| Weighted Average Shares Diluted | 1.80M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.53M | ||
| Cash and Equivalents (USD) | 4.53M | ||
| Current Assets | 4.98M | ||
| Total Assets | 4.98M | ||
| Current Liabilities | 309.39K | ||
| Total Liabilities | 309.39K | ||
| Accumulated Retained Earnings (Deficit) | -88.90M | ||
| Shareholders Equity | 4.67M | ||
| Shareholders Equity (USD) | 4.67M | ||
| Trade and Non-Trade Payables | 308.95K | ||
| Cash Flow | |||
| Net Cash Flow / Change in Cash & Cash Equivalents | -804.28K | ||
| Net Cash Flow from Operations | -804.28K | ||
| Share Based Compensation | 23.51K | ||